Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

Systematic and dynamic humoral immune reconstitution is little-known for patients with relapsed/refractory (R/R) multiple myeloma (MM) who received anti–B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy. We investigated the kinetics of B-cell, normal plasma cell, and im...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Li, Chunrui, Xia, Jieyun, Li, Ping, Cao, Jiang, Pan, Bin, Tan, Xu, Li, Hujun, Qi, Kunming, Wang, Xiangmin, Shi, Ming, Jing, Guangjun, Yan, Zhiling, Cheng, Hai, Zhu, Feng, Sun, Haiying, Sang, Wei, Li, Depeng, Zhang, Xi, Li, Zhenyu, Zheng, Junnian, Liang, Aibin, Zhou, Jianfeng, Xu, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153033/
https://www.ncbi.nlm.nih.gov/pubmed/34587230
http://dx.doi.org/10.1182/bloodadvances.2021004603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153033/
https://www.ncbi.nlm.nih.gov/pubmed/34587230
http://dx.doi.org/10.1182/bloodadvances.2021004603

Ejemplares similares